Trial Profile
A Pilot Study of Taxotere (Docetaxel), Cisplatin and 5FU (TPF) in the Palliative Treatment of Squamous Cell Carcinoma of the Head and Neck.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 15 Jun 2011
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Fluorouracil (Primary)
- Indications Head and neck cancer
- Focus Adverse reactions; Therapeutic Use
- 15 Jun 2011 New trial record